Torreya Partners is one of the most active players in the area of advising financially distressed companies in the life sciences.
Our practice involves:
• Restructuring advice
• Financial workouts
• Debt restructurings
• Exchange offers and consent solicitations
• Negotiations with venture debt providers
• M&A and asset sales in distress
• Representation of debtholders
While bankruptcies are rare in the biotechnology industry, the recent global financial crisis has caused a number of companies to fail to find financing, forcing them into bankruptcy in some cases. Bankruptcies have become more common due to the increased use of convertible securities and venture debt in the sector. In the case of bankruptcies and reorganizations we typically work with management and boards to design cost cutting plans, to help restructure outstanding debt and to achieve the highest value for any assets which are sold off.
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.